# A Clinical Study to Investigate the Long-term Use of Lacosamide as Monotherapy in Subjects Who Completed Study SP0994

> **NCT02582866** · PHASE3 · COMPLETED · sponsor: **UCB Biopharma S.P.R.L.** · enrollment: 106 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Lacosamide

## Key facts

- **NCT ID:** NCT02582866
- **Lead sponsor:** UCB Biopharma S.P.R.L.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2020-01
- **Final completion:** 2020-01
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2023-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02582866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02582866, "A Clinical Study to Investigate the Long-term Use of Lacosamide as Monotherapy in Subjects Who Completed Study SP0994". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02582866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*